Your browser is no longer supported. Please, upgrade your browser.
BLFS BioLife Solutions, Inc. monthly Stock Chart
BLFS [NASD]
BioLife Solutions, Inc.
Index- P/E- EPS (ttm)-0.27 Insider Own2.30% Shs Outstand31.64M Perf Week7.97%
Market Cap1.21B Forward P/E386.13 EPS next Y0.09 Insider Trans-62.53% Shs Float26.43M Perf Month23.49%
Income-7.40M PEG- EPS next Q-0.02 Inst Own70.80% Short Float4.87% Perf Quarter68.43%
Sales41.70M P/S28.92 EPS this Y94.50% Inst Trans44.43% Short Ratio3.78 Perf Half Y117.24%
Book/sh5.91 P/B6.08 EPS next Y-51.05% ROA-6.00% Target Price37.50 Perf Year118.43%
Cash/sh2.80 P/C12.83 EPS next 5Y10.00% ROE-7.40% 52W Range7.37 - 35.74 Perf YTD121.94%
Dividend- P/FCF446.61 EPS past 5Y22.70% ROI26.30% 52W High0.48% Beta1.50
Dividend %- Quick Ratio14.00 Sales past 5Y34.60% Gross Margin59.30% 52W Low387.25% ATR2.02
Employees151 Current Ratio15.30 Sales Q/Q71.20% Oper. Margin-4.40% RSI (14)65.63 Volatility5.85% 7.21%
OptionableYes Debt/Eq0.00 EPS Q/Q-108.80% Profit Margin-17.90% Rel Volume0.58 Prev Close33.00
ShortableYes LT Debt/Eq0.00 EarningsNov 05 AMC Payout- Avg Volume340.68K Price35.91
Recom2.10 SMA2012.32% SMA5021.02% SMA20085.40% Volume197,986 Change8.82%
Nov-10-20Initiated KeyBanc Capital Markets Overweight $40
Sep-22-20Downgrade Oppenheimer Outperform → Perform
Sep-18-20Initiated Cowen Outperform $33
Aug-11-20Downgrade The Benchmark Company Buy → Hold
Jul-08-20Reiterated Maxim Group Buy $18 → $26
Feb-24-20Initiated Lake Street Buy $25
Feb-19-20Initiated The Benchmark Company Buy $24
Feb-06-20Resumed B. Riley FBR Buy $27
Jan-08-20Initiated Stephens Overweight $23
Nov-21-19Initiated Oppenheimer Outperform $22
Jul-22-19Initiated H.C. Wainwright Buy $23
Nov-10-17Reiterated Maxim Group Buy $7 → $8
Sep-19-17Reiterated Maxim Group Buy $6 → $7
Jul-05-17Upgrade Janney Neutral → Buy $5
Mar-10-17Reiterated Maxim Group Buy $3 → $4
Jan-19-17Initiated Maxim Group Buy $3
Nov-19-20 08:00AM  
Nov-06-20 03:30PM  
Nov-05-20 04:05PM  
02:30PM  
Oct-29-20 04:05PM  
Oct-23-20 07:20AM  
Oct-22-20 04:06PM  
Oct-14-20 08:00AM  
Oct-01-20 08:00AM  
Sep-21-20 02:26PM  
08:00AM  
Sep-08-20 07:45AM  
Aug-25-20 05:53PM  
Aug-06-20 04:05PM  
Aug-05-20 08:38AM  
Aug-03-20 09:33AM  
Jul-30-20 05:45PM  
Jul-15-20 08:00AM  
Jul-07-20 12:45PM  
Jul-06-20 09:08AM  
06:57AM  
Jul-02-20 02:48PM  
07:40AM  
12:40AM  
Jul-01-20 04:02PM  
04:01PM  
Jun-26-20 11:45AM  
May-18-20 04:15PM  
May-14-20 08:30PM  
04:05PM  
May-13-20 12:52PM  
10:20AM  
May-11-20 08:00AM  
May-01-20 08:00AM  
Apr-20-20 06:44AM  
Mar-30-20 06:35PM  
Mar-28-20 08:45AM  
Mar-14-20 08:58AM  
08:38AM  
Mar-11-20 04:29PM  
02:30PM  
Feb-17-20 06:14AM  
Feb-12-20 08:00AM  
Feb-07-20 07:46AM  
Jan-22-20 05:46AM  
Jan-04-20 07:25AM  
Dec-30-19 11:35AM  
Dec-26-19 08:13PM  
Dec-19-19 09:26PM  
Dec-04-19 06:58AM  
Dec-02-19 08:00AM  
Nov-22-19 03:01AM  
Nov-12-19 04:03PM  
04:01PM  
Nov-11-19 08:07AM  
Nov-07-19 06:15PM  
08:00AM  
Oct-31-19 08:23PM  
Oct-22-19 09:13AM  
Oct-14-19 09:41AM  
08:00AM  
Sep-24-19 08:00AM  
08:00AM  
Sep-16-19 08:00AM  
Sep-11-19 10:15PM  
Sep-06-19 10:15PM  
Sep-03-19 12:30PM  
08:00AM  
Aug-28-19 08:00AM  
Aug-12-19 08:00AM  
Aug-08-19 11:23PM  
04:05PM  
08:05AM  
Aug-02-19 10:15PM  
Aug-01-19 10:33AM  
Jul-31-19 08:00AM  
Jul-30-19 08:00AM  
Jul-23-19 08:00AM  
Jul-08-19 04:31PM  
Jun-23-19 09:45PM  
Jun-10-19 08:00AM  
May-30-19 08:00AM  
May-29-19 08:00AM  
May-22-19 12:54PM  
May-09-19 08:24PM  
04:05PM  
May-02-19 10:32AM  
08:00AM  
Apr-02-19 08:00AM  
Mar-25-19 11:40AM  
Mar-20-19 08:08AM  
Mar-15-19 11:48PM  
Mar-14-19 08:26PM  
04:05PM  
08:00AM  
Mar-04-19 08:00AM  
Feb-19-19 08:00AM  
Feb-08-19 08:57AM  
Jan-29-19 04:10PM  
Jan-22-19 09:58AM  
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools for the cell and gene therapy industry in North America, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; and liquid nitrogen laboratory freezers, cryogenic equipment, and accessories. The company markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was founded in 1987 and is headquartered in Bothell, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Casdin Partners Master Fund, L10% OwnerNov 24Buy22.501,600,00036,000,0007,440,107Nov 27 05:23 PM
VILLIGER WALTER10% OwnerNov 19Sale33.3536,8481,228,8813,683,257Nov 20 08:31 PM
VILLIGER WALTER10% OwnerNov 18Sale32.3340,0001,293,2003,720,105Nov 20 08:31 PM
VILLIGER WALTER10% OwnerNov 17Sale31.3140,0001,252,4003,760,105Nov 18 08:30 PM
Rice MichaelPresident & CEONov 16Option Exercise1.6411,46118,796215,117Nov 16 09:21 PM
DE GREEF RODERICKCFO & COONov 16Option Exercise1.7610,00017,600166,293Nov 16 09:21 PM
VILLIGER WALTER10% OwnerNov 16Sale31.6836,9571,170,7983,800,105Nov 18 08:30 PM
Rice MichaelPresident & CEONov 16Sale31.2011,461357,583203,656Nov 16 09:21 PM
DE GREEF RODERICKCFO & COONov 16Sale31.3310,000313,300156,293Nov 16 09:21 PM
Rice MichaelPresident & CEONov 13Option Exercise1.6411,46118,796215,117Nov 16 09:21 PM
DE GREEF RODERICKCFO & COONov 13Option Exercise1.7610,00017,600166,293Nov 16 09:21 PM
Berard ToddChief Marketing OfficerNov 13Option Exercise2.065,00010,30068,878Nov 16 09:23 PM
Rice MichaelPresident & CEONov 13Sale31.8111,461364,574203,656Nov 16 09:21 PM
DE GREEF RODERICKCFO & COONov 13Sale31.8710,000318,700156,293Nov 16 09:21 PM
VILLIGER WALTER10% OwnerNov 13Sale31.9748,3061,544,3433,837,062Nov 16 09:23 PM
Berard ToddChief Marketing OfficerNov 13Sale32.165,000160,80063,878Nov 16 09:23 PM
Schick Joseph CDirectorNov 12Option Exercise1.905,0009,50016,875Nov 16 09:21 PM
Rice MichaelPresident & CEONov 12Option Exercise1.6411,46118,796215,117Nov 16 09:21 PM
DE GREEF RODERICKCFO & COONov 12Option Exercise1.7610,00017,600166,293Nov 16 09:21 PM
Berard ToddChief Marketing OfficerNov 12Option Exercise2.066,00012,36069,878Nov 16 09:23 PM
Schick Joseph CDirectorNov 12Sale33.126,250207,00010,625Nov 16 09:21 PM
Rice MichaelPresident & CEONov 12Sale32.3811,461371,107203,656Nov 16 09:21 PM
DE GREEF RODERICKCFO & COONov 12Sale32.1010,000321,000156,293Nov 16 09:21 PM
Schulz MarcusVice President, Global SalesNov 12Sale32.511,40045,51439,400Nov 16 09:22 PM
COHEN RAYMOND WDirectorNov 12Sale32.455,625182,53122,763Nov 16 09:22 PM
VILLIGER WALTER10% OwnerNov 12Sale32.8432,5961,070,4533,885,368Nov 16 09:23 PM
Berard ToddChief Marketing OfficerNov 12Sale32.466,000194,76063,878Nov 16 09:23 PM
VILLIGER WALTER10% OwnerNov 11Sale32.9850,0001,649,0003,917,964Nov 12 08:30 PM
VILLIGER WALTER10% OwnerNov 10Sale32.0050,0001,600,0003,967,964Nov 12 08:30 PM
VILLIGER WALTER10% OwnerNov 05Sale32.33134,4804,347,7404,017,964Nov 06 08:30 PM
VILLIGER WALTER10% OwnerNov 04Sale30.9975,0002,324,2504,152,444Nov 05 09:50 PM
VILLIGER WALTER10% OwnerNov 03Sale30.6850,0001,534,0004,227,444Nov 05 09:50 PM
VILLIGER WALTER10% OwnerOct 30Sale29.5165,0861,920,6884,277,444Nov 02 08:31 PM
VILLIGER WALTER10% OwnerOct 29Sale29.34100,0002,933,5004,342,530Nov 02 08:31 PM
VILLIGER WALTER10% OwnerOct 28Sale29.14100,0002,913,5004,442,530Oct 29 08:32 PM
VILLIGER WALTER10% OwnerOct 27Sale29.8550,0001,492,5004,542,530Oct 29 08:32 PM
VILLIGER WALTER10% OwnerOct 26Sale28.4550,0001,422,5004,592,530Oct 27 08:38 PM
VILLIGER WALTER10% OwnerOct 23Sale28.9935,8831,040,2484,642,530Oct 27 08:38 PM
VILLIGER WALTER10% OwnerOct 22Sale28.6546,3041,326,6104,678,413Oct 23 08:30 PM
VILLIGER WALTER10% OwnerOct 21Sale28.4244,6971,270,2894,724,717Oct 23 08:30 PM
Schulz MarcusVice President, Global SalesOct 12Sale28.2095326,87540,800Oct 13 08:35 PM
Rice MichaelPresident & CEOOct 08Option Exercise2.0618,75038,625222,406Oct 08 08:30 PM
VILLIGER WALTER10% OwnerOct 08Sale29.525,818171,7474,769,414Oct 13 08:34 PM
Rice MichaelPresident & CEOOct 08Sale28.5518,750535,313203,656Oct 08 08:30 PM
VILLIGER WALTER10% OwnerOct 07Sale29.6946,5421,381,8324,775,232Oct 13 08:34 PM
Rice MichaelPresident & CEOOct 06Option Exercise2.0618,75038,625222,406Oct 08 08:30 PM
Rice MichaelPresident & CEOOct 06Sale29.5418,750553,875203,656Oct 08 08:30 PM
Berard ToddChief Marketing OfficerSep 29Sale28.6380823,13363,878Oct 01 09:41 PM
Foster Karen A.Chief Quality OfficerSep 29Sale28.6397727,97250,908Oct 01 09:41 PM
DE GREEF RODERICKCFO & COOSep 29Sale28.631,78150,99056,293Oct 01 09:41 PM
Rice MichaelPresident & CEOSep 29Sale28.634,690134,275203,656Oct 01 09:40 PM
Mathew Aby J.Exec VP & Chief Scientific OffSep 29Sale28.631,85853,195180,802Oct 01 09:40 PM
Mathew Aby J.Exec VP & Chief Scientific OffSep 23Sale26.845,000134,200182,660Sep 25 08:30 PM
Rice MichaelPresident & CEOSep 10Option Exercise2.0618,75038,625227,096Sep 10 08:00 PM
Rice MichaelPresident & CEOSep 10Sale23.2418,750435,750208,346Sep 10 08:00 PM
Rice MichaelPresident & CEOSep 08Option Exercise2.0618,75038,625227,096Sep 10 08:00 PM
Rice MichaelPresident & CEOSep 08Sale21.6418,750405,750208,346Sep 10 08:00 PM
VILLIGER WALTER10% OwnerAug 27Sale20.6121,717447,5874,821,774Aug 28 08:33 PM
Foster Karen A.Chief Quality OfficerAug 26Sale20.481793,66651,885Aug 28 08:30 PM
Mathew Aby J.Exec VP & Chief Scientific OffAug 26Sale20.482555,222187,660Aug 28 08:31 PM
Rice MichaelPresident & CEOAug 26Sale20.4887717,961208,346Aug 28 08:32 PM
VILLIGER WALTER10% OwnerAug 26Sale21.0028,283593,9434,843,491Aug 28 08:33 PM
Rice MichaelPresident & CEOAug 13Option Exercise2.0618,75038,625227,973Aug 13 08:30 PM
Rice MichaelPresident & CEOAug 13Sale18.6418,750349,500209,223Aug 13 08:30 PM
Mathew Aby J.Exec VP & Chief Scientific OffAug 12Sale19.685,00098,400187,915Aug 13 08:31 PM
Rice MichaelPresident & CEOAug 11Option Exercise2.0618,75038,625227,973Aug 13 08:30 PM
Rice MichaelPresident & CEOAug 11Sale19.9118,750373,313209,223Aug 13 08:30 PM
Mathew Aby J.Exec VP & Chief Scientific OffAug 11Sale20.0310,000200,300192,915Aug 13 08:31 PM
VILLIGER WALTER10% OwnerAug 10Sale21.6350,0001,081,5004,871,774Aug 11 08:32 PM
VILLIGER WALTER10% OwnerAug 07Sale21.0150,0001,050,5004,921,774Aug 11 08:32 PM
Rice MichaelPresident & CEOJul 16Option Exercise2.0618,75038,625232,973Jul 16 08:30 PM
Rice MichaelPresident & CEOJul 16Sale19.3018,750361,875214,223Jul 16 08:30 PM
Mathew Aby J.Exec VP & Chief Scientific OffJul 15Sale19.4810,000194,800202,915Jul 17 08:00 PM
Rice MichaelPresident & CEOJul 14Option Exercise2.0618,75038,625232,973Jul 16 08:30 PM
Rice MichaelPresident & CEOJul 14Sale18.6718,750350,063214,223Jul 16 08:30 PM
VILLIGER WALTER10% OwnerJul 06Sale18.9723,372443,3674,971,179Jul 08 09:37 PM
Casdin Partners Master Fund, L10% OwnerJul 02Buy14.50305,5834,430,9545,840,107Jul 02 04:48 PM
VILLIGER WALTER10% OwnerJul 02Sale18.5717,088317,3244,994,551Jul 08 09:37 PM
GIRSCHWEILER THOMASDirectorJul 02Sale14.50305,5834,430,9541,642,774Jul 02 06:32 PM
Casdin Partners Master Fund, L10% OwnerJul 01Buy14.50685,0009,932,5005,534,524Jul 02 04:48 PM
Rice MichaelPresident & CEOJun 19Option Exercise2.0618,75038,625232,973Jun 23 08:00 PM
Rice MichaelPresident & CEOJun 19Sale16.3718,750306,938214,223Jun 23 08:00 PM
Rice MichaelPresident & CEOJun 11Option Exercise2.0618,75038,625232,973Jun 15 08:31 PM
Rice MichaelPresident & CEOJun 11Sale15.0118,750281,438214,223Jun 15 08:31 PM
Mathers JamesChief Revenue OfficerMay 28Sale16.871212,04119,856Jun 01 08:01 PM
Foster Karen A.Chief Quality OfficerMay 28Sale16.871702,86852,064Jun 01 08:02 PM
Rice MichaelPresident & CEOMay 28Sale16.875168,705214,223Jun 01 08:00 PM
Mathew Aby J.Exec VP & Chief Scientific OffMay 28Sale16.872424,083212,915Jun 01 08:01 PM
Casdin Partners Master Fund, L10% OwnerMay 22Buy10.50476,1915,000,0064,849,524May 26 01:54 PM
GIRSCHWEILER THOMASDirectorMay 22Sale10.50476,1915,000,0061,948,357Jun 03 08:00 PM
Mathew Aby J.Exec VP & Chief Scientific OffMay 15Option Exercise2.0610,00020,600223,157May 15 08:04 PM
Rice MichaelPresident & CEOMay 15Option Exercise2.0618,75038,625233,489May 15 08:05 PM
Rice MichaelPresident & CEOMay 15Sale14.2318,750266,813214,739May 15 08:05 PM
Mathew Aby J.Exec VP & Chief Scientific OffMay 15Sale14.2910,000142,900213,157May 15 08:04 PM
Casdin Partners Master Fund, L10% OwnerMay 14Buy10.501,904,76220,000,0014,373,333May 18 04:47 PM
Mathew Aby J.Exec VP & Chief Scientific OffMay 13Option Exercise2.0610,00020,600223,157May 13 08:00 PM
Rice MichaelPresident & CEOMay 13Option Exercise2.0618,75038,625233,489May 15 08:05 PM
GIRSCHWEILER THOMASDirectorMay 13Sale14.90492,2777,334,9272,424,548Jun 03 08:00 PM
VILLIGER WALTER10% OwnerMay 13Sale14.90631,1589,404,2544,526,236Jun 03 08:01 PM
Rice MichaelPresident & CEOMay 13Sale15.4518,750289,688214,739May 15 08:05 PM